Immunization with a multisubunit vaccine considerably reduces establishment of infective larvae in a rodent model of Brugia malayi

Comparative Immunology, Microbiology and Infectious Diseases

Volumn 36, Issue 5, 2013, Pages 507-519

  Shrivastava, Nidhi ^a   Singh, Prashant Kumar ^a   Nag, Jeetendra Kumar ^a   Kushwaha, Susheela ^a   Misra Bhattacharya, Shailja ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Bm TPP; BmAF Myo; Expression; Recombinant protein

Indexed keywords

ADULT FEMALE HEAVY CHAIN MYOSIN; BISPHOSPHOGLYCERATE MUTASE; BRUGIAN FILARIASIS VACCINE; FREUND ADJUVANT; GAMMA INTERFERON; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G23 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; IMMUNOGLOBULIN G2B ANTIBODY; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; MYOSIN HEAVY CHAIN; PARASITE ANTIGEN; PHOSPHATASE; PHOSPHATE BUFFERED SALINE; PLACEBO; REACTIVE OXYGEN METABOLITE; RECOMBINANT PROTEIN; TREHALOSE 6 PHOSPHATE PHOSPHATASE; UNCLASSIFIED DRUG; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTHELMINTIC ACTIVITY; ANTIBODY TITER; ARTICLE; BRUGIA MALAYI; BRUGIAN FILARIASIS; CELLULAR IMMUNITY; CHEMOPROPHYLAXIS; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG DETERMINATION; DRUG EFFICACY; DRUG FORMULATION; DRUG MIXTURE; DRUG SYNTHESIS; HOST PARASITE INTERACTION; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; LYMPHOCYTE PROLIFERATION; MICROFILARIA (NEMATODE LARVA); NONHUMAN; PROVOCATION TEST; RAT; RISK REDUCTION;

ANIMALIA; BRUGIA MALAYI; RODENTIA; VERMES;

BM-TPP; BMAF-MYO; EXPRESSION; RECOMBINANT PROTEIN;

ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; BRUGIA MALAYI; CYTOKINES; ELEPHANTIASIS, FILARIAL; IMMUNIZATION; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LARVA; LYMPHOCYTE ACTIVATION; MURINAE; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; REACTIVE OXYGEN SPECIES; RECOMBINANT PROTEINS; VACCINES, SUBUNIT; VACCINES, SYNTHETIC;

EID: 84881556248     PISSN: 01479571     EISSN: 18781667     Source Type: Journal    
DOI: 10.1016/j.cimid.2013.05.003     Document Type: Article

References (46)

1. Taylor M.J., Hoerauf A., Bockarie M. Lymphatic filariasis and onchocerciasis. Lancet 2010, 376(9747):1175-1185.
2. Wolstenholme A.J., Fairweather I., Prichard R., Von Samson-Himmelstjerna G., Sangster N.C. Drug resistance in veterinary helminths. Trends in Parasitology 2004, 20:469-476.
3. Bourguinat C., Pion S.D., Kamgno J., Gardon J., Duke B.O., Boussinesq M., et al. Genetic selection of low fertile Onchocerca volvulus by ivermectin treatment. PLoS Neglected Tropical Disease 2007, 1(1):e72.
4. Lustigman S., McCarter J.P. Ivermectin resistance in Onchocerca volvulus: toward a genetic basis. PLoS Neglected Tropical Disease 2007, 1(1):e76.
5. Dabir S., Dabir P., Goswami K., Reddy M.V. Prophylactic evaluation of recombinant extracellular superoxide dismutase of Brugia malayi in jird model. Vaccine 2008, 26(29-30):3705-3710.
6. Rathaur S., Yadav M., Gupta S., Anandharaman V., Reddy M.V. Filarial glutathione-S-transferase: a potential vaccine candidate against lymphatic filariasis. Vaccine 2008, 26(32):4094-4100.
7. Sharmila S., Christiana I., Kiran P., Reddy M.V., Kaliraj P. The adjuvant-free immunoprotection of recombinant filarial protein Abundant Larval Transcript-2 (ALT-2) in Mastomys coucha and the immunoprophylactic importance of its putative signal sequence. Experimental Parasitology 2011, 129(3):247-253.
8. Dakshinamoorthy G., Samykutty A.K., Munirathinam G., Shinde G.B., Nutman T., Reddy M.V., et al. Biochemical characterization and evaluation of a Brugia malayi small heat shock protein as a vaccine against lymphatic filariasis. PLoS ONE 2012, 7(4):e34077.
9. Kedzierski L., Black C.G., Goschnick M.W., Stowers A.W., Coppel R.L. Immunization with a combination of merozoite surface proteins 4/5 and 1 enhances protection against lethal challenge with Plasmodium yoelii. Infection and Immunity 2002, 70(12):6606-6613.
10. Burns J.M., Flaherty P.R., Romero M.M., Weidanz W.P. Immunization against Plasmodium chabaudi malaria using combined formulations of apical membrane antigen-1 and merozoite surface protein-1. Vaccine 2003, 21(17-18):1843-1852.
11. Moreno J., Nieto J., Masina S., Cañavate C., Cruz I., Chicharro C., et al. Immunization with H1, HASPB1 and MML leishmania proteins in a vaccine trial against experimental canine leishmaniasis. Vaccine 2007, 25(29):5290-5300.
12. Shi Q., Lynch M.M., Romero M., Burns J.M. Enhanced protection against malaria by a chimeric merozoite surface protein vaccine. Infection and Immunity 2007, 75(3):1349-1358.
13. Vanam U., Pandey V., Prabhu P.R., Dakshinamurthy G., Reddy M.V., Kaliraj P. Evaluation of immunoprophylactic efficacy of Brugia malayi transglutaminase (BmTGA) in single and multiple antigen vaccination with BmALT-2 and BmTPX for human lymphatic filariasis. American Journal of Tropical Medicine and Hygiene 2009, 80(2):319-324.
14. Anand S.B., Kodumudi K.N., Reddy M.V., Kaliraj P. A combination of two Brugia malayi filarial vaccine candidate antigens (BmALT-2 and BmVAH) enhances immune responses and protection in jirds. Journal of Helminthology 2011, 85(4):442-452.
15. Verma S., Bansal I., Vedi S., Saxena J.K., Katoch V.M., Misra-Bhattacharya S. Molecular cloning, purification and characterisation of myosin of human lymphatic filarial parasite Brugia malayi. Parasitology Research 2008, 102(3):481-490.
16. Bennuru S., Semnani R., Meng Z., Ribeiro J.M., Veenstra T.D., Nutman T.B. Brugia malayi excreted/secreted proteins at the host/parasite interface: stage- and gender-specific proteomic profiling. PLoS Neglected Tropical Disease 2009, 3(4):e410.
17. Obwaller A., Duchêne M., Bruhn H., Steipe B., Tripp C., Kraft D., et al. Recombinant dissection of myosin heavy chain of Toxocara canis shows strong clustering of antigenic regions. Parasitology Research 2001, 87(5):383-389.
18. Vedi S., Dangi A., Hajela K., Misra-Bhattacharya S. Vaccination with 73kDa recombinant heavy chain myosin generates high level of protection against Brugia malayi challenge in jird and mastomys models. Vaccine 2008, 26(47):5997-6005.
19. Moreno Y., Geary T.G. Stage- and gender-specific proteomic analysis of Brugia malayi excretory-secretory products. PLoS Neglected Tropical Disease 2008, 2(10):e326.
20. Singh U., Misra S., Murthy P.K., Katiyar J.C., Agrawal A., Sircar A.R. Immunoreactive molecules of Brugia malayi and their diagnostic potential. Serodiagnosis and Immunotherapy in Infectious Disease 1997, 8:207-212.
21. Zhang Y., Foster J.M., Kumar S., Fougere M., Carlow CK Cofactor independent phosphoglycerate mutase has an essential role in Caenorhabditis elegans and is conserved in parasitic nematodes. Journal of Biological Chemistry 2004, 279:37185-37190.
22. Kushwaha S., Singh P.K., Rana A.K., Misra-Bhattacharya S. Cloning, expression, purification and kinetics of trehalose-6-phosphate phosphatase of filarial parasite Brugia malayi. Acta Tropica 2011, 119(2-3):151-159.
23. Kolaskar A.S., Tongaonkar P.C. A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Letters 1990, 276:172-174.
24. Singh H., Raghava G.P. ProPred: prediction of HLA-DR binding sites. Bioinformatics 2001, 17(12):1236-1237.
25. Saha S., Raghava G.P.S. BcePred: Prediction of Continuous B-cell Epitopes in Antigenic Sequences Using Physico-chemical Properties 2004, 3239197-3239204. LNCS.
26. Maguire G.A., Kumararatne D.S., Joyce H.J. Are there any clinical indications for measuring IgG subclass?. Annals of Clinical Biochemistry 2002, 39:374-377.
27. Singh M., Shakya S., Soni V.K., Dangi A., Kumar N., Bhattacharya S.M. The n-hexane and chloroform fractions of Piper betle L. trigger different arms of immune responses in BALB/c mice and exhibit antifilarial activity against human lymphatic filarid Brugia malayi. International Immunopharmacology 2009, 9(6):716-728.
28. Zurgil N., Shafran Y., Afrimzon E., Fixler D., Shainberg A., Deutsch M. Concomitant real-time monitoring of intracellular reactive oxygen species and mitochondrial membrane potential in individual living promonocytic cells. Journal of Immunological Methods 2006, 316(1-2):27-41.
29. Misra S., Mukherjee M., Dikshit M., Chaterjee R.K. Cellular response of Mastomys and gerbil in experimental filariasis. Tropical Medicine and International Health 1998, 3(2):124-129.
30. Yates J.A., Higashi G.I. Brugia malayi: vaccination of jirds with 60 cobalt-attenuated infective stage larvae protects against homologous challenge. American Journal of Tropical Medicine and Hygiene 1985, 34(6):1132-1137.
31. Chenthamarakshan V., Reddy M.V., Harinath B.C. Immunoprophylactic potential of a 120kDa Brugia malayi adult antigen fraction, BmA-2, in lymphatic filariasis. Parasite Immunology 1995, 17(6):277-285.
32. Dixit S., Gaur R.L., Sahoo M.K., Joseph S.K., Murthy P.S., Murthy P.K. Protection against L3 induced Brugia malayi infection in Mastomys coucha pre-immunized with BmAFII fraction of the filarial adult worm. Vaccine 2006, 24(31-32):5824-5831.
33. Thirugnanam S., Pandiaraja P., Ramaswamy K., Murugan V., Gnanasekar M., Nandakumar K., et al. Brugia malayi: comparison of protective immune responses induced by Bm-alt-2 DNA, recombinant Bm-ALT-2 protein and prime-boost vaccine regimens in a jird model. Experimental Parasitology 2007, 116(4):483-491.
34. Shakya S., Singh P.K., Kushwaha S., Misra-Bhattacharya S. Adult Brugia malayi approximately 34 kDa (BMT-5) antigen offers Th1 mediated significant protection against infective larval challenge in Mastomys coucha. Parasitology International 2009, 58(4):346-353.
35. Anand S.B., Rajagopal V., Kaliraj P. Brugia malayi thioredoxin peroxidase as a potential vaccine candidate antigen for lymphatic filariasis. Applied Biochemistry and Biotechnology 2012, [Epub ahead of print].
36. Ravindran B.A.K., Satapathy P.K., Sahoo J.J., Geddam B. Protective immunity in human Bancroftian filariasis: inverse relationship between antibodies to microfilarial sheath and circulating filarial antigens. Parasite Immunology 2000, 22:633-637.
37. Martin C., Saeftel M., Vuong P.N., Babayan S., Fischer K., Bain O., et al. B-cell deficiency suppresses vaccine-induced protection against murine filariasis but does not increase the recovery rate for primary infection. Infection and Immunity 2001, 69(11):7067-7073.
38. Bethony J., Loukas A., Smout M., Brooker S., Mendez S., Plieskatt J., et al. Antibodies against a secreted protein from hookworm larvae reduce the intensity of hookworm infection in humans and vaccinated laboratory animals. FASEB Journal 2005, 19(12):1743-1745.
39. Rajan B., Ramalingam T., Rajan T.V. Critical role for IgM in host protection in experimental filarial infection. Journal of Immunology 2005, 175:1827-1833.
40. Babu S., Blauvelt C.P., Kumaraswami V., Nutman T.B. Cutting edge: diminished T cell TLR expression and function modulates the immune response in human filarial infection. Journal of Immunology 2006, 176(7):3389-3885.
41. Harnett W., Harnett M.M. What causes lymphocyte hyporesponsiveness during filarial nematode infection?. Trends in Parasitology 2006, 22(3):105-110.
42. El Bouhdidi A., Truyens C., Rivera M.T., Bazin H., Carlier Y. Trypanosoma cruzi infection in mice induces a polyisotypic hypergammaglobuline-mia and parasite-specific response involving high IgG2a concentrations and highly avid IgG1 antibodies. Parasite Immunology 1994, 16(2):69-76.
43. Babayan S.A., Attout T., Harris A., Taylor M.D., Le Goff L., Vuong P.N., et al. Vaccination against filarial nematodes with irradiated larvae provides long-term protection against the third larval stage but not against subsequent life cycle stages. International Journal for Parasitology 2006, 36(8):903-914.
44. Babu S., Ganley L.M., Klei T.R., Leonard D., Shultz L.D., Rajan T.V. Role of gamma interferon and interleukin-4 in host defense against the human filarial parasite Brugia malayi. Infection and Immunity 2000, 68(5):3034-3035.
45. Gupta R., Bajpai P., Tripathi L.M., Srivastava V.M.L., Jain S.K., Misra-Bhattacharya S. Macrophages in the development of protective immunity against experimental Brugia malayi infection. Parasitology 2004, 129(3):311-323.
46. Rollman E., Bråve A., Boberg A., Gudmundsdotter L., Engström G., Isaguliants M., et al. The rationale behind a vaccine based on multiple HIV antigens. Microbes and Infection 2005, 7(14):1414-1423.